Showing posts with label clindamycin. Show all posts
Showing posts with label clindamycin. Show all posts

Friday, December 28, 2012

Incidence and seasonal distribution of methicillin-resistant Staphylococcus aureus in adult outpatients at a clinic in Buenos Aires province: period 2006 to 2011


Incidence and seasonal distribution of methicillin-resistant Staphylococcus aureus in adult outpatients at a clinic in Buenos Aires province: period 2006 to 2011


Oct 2012

[Article in Spanish]

Source

Servicio de Infectología y Microbiología Clínica, Clínica Privada Independencia. Luis María Drago 5681 (1605) Munro, Provincia de Buenos Aires, Argentina. E-mail: mtveron@gmail.com.

Abstract


In the last decade there was a significant growth of community-acquired methicillin-resistant Staphylococcus aureus(ca-MrSa). We herein describe the annual incidence, seasonal distribution, antimicrobial resistance and phenotypes of MrSain adult outpatients. From january 2006 to december 2011, 173 strains of S. aureus were studied, 77 (45 %) of which wereMrSa. The annual incidence per 100 processed materials increased from 0.13 in 2006 to 0.62 in 2011 due to the oxacillin-resistant phenotype, showing peaks in springsummer until december 2008 and subsequent peaks in autumn-winter. The antimicrobial resistance profile was: erythromycin 24 (31 %), clindamycin 22 (29 %), gentamicin 23 (30 %), ciprofloxacin 13 (17 %), trimethoprim-sulfamethoxazole 3 (4 %), chloramphenicol 2 (3 %), rifampicin 2 (3 %), and minocycline 0. Sixteen phenotypes were identified; the oxacillin-resistant phenotype being the most common, accounting for 53 % (41 isolates) and exhibiting an increase ranging from 31 % to 65 %. The empirical treatment of infections was changed and prevention measures were implemented among contacts.

Monday, November 24, 2008

The prevalence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) in skin abscesses presenting to the pediatric emergency dep

The prevalence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) in skin abscesses presenting to the pediatric emergency department.
N C Med J. 2008

Magilner D, Byerly MM, Cline DM.
Wake Forest University-School of Medicine, USA.
dmagilne@wfubmc.edu

BACKGROUND: Community-acquired methicillin resistant Staphylococcus aureus (CA-MRSA) infections have been increasing. The most common of these infections present as skin abscesses. The objectives of this study were to prospectively determine the prevalence of CA-MRSA in abscesses in the population of a pediatric emergency department, to determine antibiotic sensitivity patterns of the CA-MRSA isolates, and to describe the patient population that presented with skin abscesses.

METHODS: We conducted a prospective study of children under the age of 18 years who presented to our pediatric emergency department with a skin abscess that required incision and drainage. Pus from these abscesses was sent for culture to determine the causative agent, and antibiotic sensitivities were reported. Characteristics of the patient population that presented with these abscesses were examined.

RESULTS: Sixty-eight patients were enrolled over an 18-month period. Of these, 60 (88%) had cultures positive for Staphylococcus aureus (S. Aureus). Of these 60 patients, 51 (85%) were identified as CA-MRSA by their resistance patterns. All of the CA-MRSA isolates were sensitive to trimethoprim/sulfamethoxisole; 6 (10%) were either resistant or intermittently resistant to clindamycin.

LIMITATIONS: The study was conducted on a convenience sample of patients and enrolled a relatively small number of patients.

CONCLUSIONS: CA-MRSA is responsible for the vast majority of skin abscesses presenting to the pediatric emergency department. CA-MRSA isolates are likely to be sensitive to trimethoprim/sulfamethoxisole or clindamycin, although there is some resistance to clindamycin.

PubMed